Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

LSL Pharma Group Inc

LSL.V ✗ NOT COMPLIANT ☆ Track — members

TSX Venture · Healthcare · Pharmaceuticals ·

Canada Micro Cap Analyst: N/A

Last Close

$0.27

▲ +4.17%

Market Cap $34.12M · Vol 31.67K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$34.12M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

60.00

Momentum

Beta

-0.47

vs Market

52W High

$0.40

34.88% below

52W Low

$0.22

28.02% above

Volume

31.67K

Avg 33.58K

P/B

1.64

Price-to-book

ROE

N/A

Return on equity

Free Float

75.36%

Public shares

Shariah Compliance8 STANDARDS

✗ LSL Pharma Group Inc (LSL.V) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does LSL.V pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+5.63%

+15.38%

+5.63%

-25.00%

YTD

+7.14%

-6.25%

-13.13%

-62.50%

Financials & Valuation

TTM · Annual

Total Revenue	$20.94M
Net Income	$-2,054,795.00
Revenue Growth (YoY)	+85.66%
Gross Margin	15.51%
Operating Margin	-8.04%
Net Profit Margin	-9.81%
ROE	N/A
ROA · ROIC	-4.50% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.43
P/B	1.64
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	126.73M

Technical Indicators

50-Day SMA	$0.24
200-Day SMA	$0.28
RSI (14)	60.00
Beta	-0.47
52-Week High	$0.40
52-Week Low	$0.22

Volume Today	31.67K
Avg Daily Volume (30D)	33.58K
Relative Volume	0.94x
Volatility (10D)	37.63
Volatility (30D)	62.84
Free Float	75.36%

Analyst Consensus

N/A

Current Price $0.27

Mean Target N/A

52W Low$0.22 52W High$0.40

Current

Target

$0.22 $0.40

Current Analyst target

· 0 analysts

Identifiers

ExchangeTSX Venture

FIGIBBG001V04B49

ISINCA50190N1042

CountryCanada

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in development, manufacturing and commercialization of sterile ophthalmic pharmaceutical products, as well as pharmaceutical, cosmetic and natural health products in solid, semi-solid and liquid dosage forms. Its segments include CMO activities and Integrated Eye-care pharmaceutical company. Its wholly owned subsidiaries include Steri-Med Pharma Inc. (Steri-Med), LSL Laboratory Inc. (LSL Laboratory), Virage Sante Inc., Dermolab Pharma Ltd. (Dermolab), Du-Var Laboratory Inc. and Juno OTC Inc. (Juno OTC). LSL Laboratory manufactures natural health products in solid dosage forms, mainly for third-party pharmaceutical clients, as well as a list of private labelled products. Dermolab manufactures liquid and semi-solid pharmaceutical, natural health and cosmetic products. Steri-Med is its sterile Eye-care manufacturing operation. Juno OTC is a supplier in Canadian private label consumer healthcare OTC market.